MetaADEDB 2.0 @ LMMD
Cisplatin
(BSJGASKRWFKGMV-UHFFFAOYSA-L)
Structure
SMILES
Cl[Pt+2]Cl.N.N
Type(s)
Approved
ATC code(s)
L01XA01
Molecular Formula:
Cl2H6N2Pt++
Molecular Weight:
300.045
Log P:
2.0243
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
2
TPSA:
6.48
CAS Number(s):
15663-27-1
Synonym(s)
1.
Cisplatin
2.
Platinum Diamminodichloride
3.
cis-Diamminedichloroplatinum(II)
4.
cis-Dichlorodiammineplatinum(II)
5.
Biocisplatinum
6.
Dichlorodiammineplatinum
7.
NSC-119875
8.
Platidiam
9.
Platino
10.
Platinol
11.
cis-Diamminedichloroplatinum
12.
cis-Platinum
13.
Diamminodichloride, Platinum
14.
cis Diamminedichloroplatinum
15.
cis Platinum
External Link(s)
MeSHD002945
PubChem Compound131841612
23644016
441203
BindingDB92393
92386
ChEBI27899
124988
35852
DrugBankDB00515
Therapeutic Target DatabaseD0U5HU
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1DermatitisFAERS: 5US FAERS
2PharyngitisFAERS: 5US FAERS
3Acute kidney injuryFAERS: 3US FAERS
4EnterocolitisFAERS: 3US FAERS
5IleusFAERS: 3US FAERS
6FlushingFAERS: 2US FAERS
7HypotensionFAERS: 2US FAERS
8Intestinal PerforationFAERS: 2US FAERS
9VomitingFAERS: 2US FAERS
10Abdominal PainFAERS: 1OFFSIDES
US FAERS
11Administration site extravasationFAERS: 1US FAERS
12Anaphylactic shockFAERS: 1US FAERS
13AscitesFAERS: 1US FAERS
14AstheniaFAERS: 1US FAERS
15BicytopeniaFAERS: 1US FAERS
16BronchospasmFAERS: 1US FAERS
17ChillsFAERS: 1US FAERS
18DizzinessFAERS: 1US FAERS
19EnteritisFAERS: 1US FAERS
20ErythemaFAERS: 1US FAERS
21ExtravasationFAERS: 1US FAERS
22Histiocytosis haematophagicFAERS: 1US FAERS
23NeutropeniaFAERS: 1US FAERS
24Peripheral swellingFAERS: 1US FAERS
25PresyncopeFAERS: 1US FAERS
26SepsisFAERS: 1US FAERS
27TachycardiaFAERS: 1US FAERS
28Throat irritationFAERS: 1US FAERS
29TinnitusFAERS: 1US FAERS
30Weight decreasedFAERS: 1US FAERS
31Abdominal discomfortOFFSIDES
32AlopeciaOFFSIDES
33AnorexiaOFFSIDES
34Blood potassium decreasedOFFSIDES
35Blurred visionOFFSIDES
36BronchitisOFFSIDES
37Chemotherapeutic drug level increasedOFFSIDES
38Circumstance or information capable of leading to medication errorOFFSIDES
39ColitisOFFSIDES
40Corneal erosionOFFSIDES
41DeafnessOFFSIDES
42DemyelinationOFFSIDES
43Dental cariesOFFSIDES
44Disease ProgressionOFFSIDES
45Drug withdrawal headacheOFFSIDES
46DysgeusiaOFFSIDES
47Endodontic procedureOFFSIDES
48Febrile NeutropeniaOFFSIDES
49Full blood count decreasedOFFSIDES
50Granulocyte count decreasedOFFSIDES
51HiccoughOFFSIDES
52Livedo ReticularisOFFSIDES
53Markedly reduced dietary intakeOFFSIDES
54MyelodysplasiaOFFSIDES
55NeuralgiaOFFSIDES
56Neutrophil count decreasedOFFSIDES
57Optic Disc EdemaOFFSIDES
58Osteomyelitis drainageOFFSIDES
59OsteomyelitisOFFSIDES
60OsteoporosisOFFSIDES
61PainOFFSIDES
62Productive CoughOFFSIDES
63Recall phenomenonOFFSIDES
64SynovitisOFFSIDES
65Tooth ExtractionOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.